2 Cannabis Stocks That Were Recently Upgraded

: CGC | Canopy Growth Corporation News, Ratings, and Charts

CGC – A flurry of positive news releases related to state-level marijuana legalization and significant progress on cannabis reform at the federal level are making analysts optimistic about the upside potential of several fundamentally sound stocks in the cannabis sector. For example, the industry’s promising outlook has encouraged analysts to upgrade Canopy Growth (CGC) and Tilray (TLRY). So, let’s discuss.

With Amazon Inc. (AMZN) now actively supporting The Marijuana Opportunity Reinvestment and Expungement Act of 2021 (MORE Act)—federal legislation that would decriminalize cannabis at the federal level and enact criminal and social justice reforms—cannabis stocks are once again grabbing the limelight. On June 1, in a blog post, Amazon’s worldwide consumer division CEO Dave Clark said, “We hope other employers will join us, and that policymakers will act swiftly to pass this law.”

Support for marijuana legalization is at an all-time high now. Last month, Jerry Nadler, the U.S. House Judiciary Committee Chairman, reintroduced the MORE Act amid a strong cry for federal level reform from social justice advocacy groups and growing support for marijuana legalization at the state level. This, along with the U.S. Drug Enforcement Administrations’ recent announcement that it would be issuing licenses to several cannabis growing facilities, has made analysts extremely optimistic about the industry’s growth prospects.

Furthermore, analysts recently upgraded the ratings of prominent cannabis players Canopy Growth Corporation (CGC) and Tilray, Inc. (TLRY). And we think their diverse product portfolios and expansive distribution networks should help the stocks to deliver solid returns in the near term.

Click here to check out our new  Cannabis Industry Report for 2021

Canopy Growth Corporation (CGC)

Based in Smiths Falls, Canada, CGC is a cannabis operator that produces and sells  cannabis and hemp-based products for medical and recreational purposes in Canada, the United States, and Germany. The company operates through Global Cannabis and Other Consumer Products segments, and sells its products under the Tweed, Quatreau, Deep Space and Spectrum Therapeutics brand names. MKM Partners upgraded CGC to ‘Buy’ from ‘Neutral’ last month.

In April, CGC signed a distribution agreement with Southern Glazer’s Wine & Spirits, the world’s leading distributor of beverage alcohol, under which CGC will leverage the company’s established distribution network to market its portfolio of CBD-infused beverages in the United States. This strategic partnership should enable CGC to reach consumers across the U.S and capitalize on the strong consumer interest in the CBD-infused beverage category.

Also in April, the company agreed with the Supreme Cannabis Company, Inc. to acquire all its issued and outstanding common shares for approximately $435 million. The acquisition is expected to strengthen CGC’s brand portfolio and solidify its position in the Canadian recreational market for cannabis.

CGC’s total revenue increased 38% year-over-year to CAD$148.4 million (US$122.54) in the fourth quarter, ended March 31, 2021. Its gross margin was 7% as compared to negative 85% in the fourth quarter of 2020. The company’s cash and short-term investments amounted to CAD$2.3 billion (US$1.90 billion) for this period, representing a CAD$0.3 billion (US$0.25 billion)increase from the same period last year.

A consensus EPS estimate for the fiscal period ending March 31, 2022, represents a 74.2% improvement year-over-year. The $649.32 million  consensus revenue estimate for the next year represents a 29.1% increase from the same period last year. CGC’s stock has gained 43.9% over the past year.

Tilray, Inc. (TLRY)

Formerly known as Aphria Inc., Canada-based TLRY is a producer and distributor of medical cannabis and cannabinoids. The company sells hemp-based foods and alcoholic beverages, as well as medical cannabis in extracts and dried flower forms to patients, pharmacies, hospitals, governments, and physicians. Analysts at Cantor Fitzgerald upgraded TLRY to ‘Overweight’ from ‘Neutral.’

On June 8, the company launched Symbios to broaden its medical brand portfolio in Canada and provide patients with a comprehensive assortment of cannabinoid products to promote health, and wellbeing. This addition should allow the company to meet the needs and preferences of patients and drive sales growth.

Last month, TLRY and Aphria, Inc. completed a  business combination, thereby creating the new “Tilray” in the global cannabis industry. Its  renewed business strength should  allow TLRY to fund its global expansion strategy and build the leading cannabis-focused CPG company.

TLRY’s total revenue increased 20.5% year-over-year to $56.56 million in its  fiscal fourth quarter, ended December 31, 2020. The company’s cannabis segment revenue increased 46% year-over-year to $41.2 million. Its gross margin under the cannabis segment was 33% during this quarter versus 16% in the fourth quarter of 2019.

Analysts expect TLRY’s EPS for the quarter ending June 2021 to increase 89.2% year-over-year. The company’s revenue is likely to increase 70.3% for  2022. Over the past year, the stock has gained 111.6%.

Click here to check out our new  Cannabis Industry Report for 2021


CGC shares were trading at $25.71 per share on Thursday morning, down $0.03 (-0.12%). Year-to-date, CGC has gained 4.34%, versus a 13.70% rise in the benchmark S&P 500 index during the same period.


About the Author: Imon Ghosh


Imon is an investment analyst and journalist with an enthusiasm for financial research and writing. She began her career at Kantar IMRB, a leading market research and consumer consulting organization. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CGCGet RatingGet RatingGet Rating
TLRYGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

2nd Half of 2021 Stock Market Outlook

The stock market (SPY) has continued on a bullish path to start 2021. Yet it is not quite the same glorious bull run we enjoyed from the lows of last year. This market has become more volatile and with less upside potential. However, there is still plenty of money to be made if you look in the right places. That is the very nature of the new presentation I put together. So read on for more info…

:  |  News, Ratings, and Charts

Better Meme Stock: Wendy's or Palantir Technologies?

2021 has been the year of the meme stock. Meme stocks have risen higher and faster than many of the traditional big name high flyers this year. These stocks are being pushed higher by traders on social media. Wendy's Company (WEN) and Palantir Technologies (PLTR) are two stocks that have recently generated a lot of attention, but which is a better buy? Read more to find out.

:  |  News, Ratings, and Charts

Grom Social Has Blossomed Into an Impressive Social Media Platform

Tech entrepreneur Zach Marks adds more innovation and content to a safe space for kids

:  |  News, Ratings, and Charts

4 ETFs to Buy if Inflation is Transitory

Recently, we've seen the biggest inflation reading since 2008. However, the current consensus is that inflation may be peaking. If this is the case, then the Invesco Dynamic Leisure and Entertainment ETF (PEJ), US Global Jets ETF (JETS), Invesco QQQ Trust (QQQ), and the SPDR S&P Dividend ETF (SDY) are 4 ETFs worth buying. 

:  |  News, Ratings, and Charts

Grom Social Has Blossomed Into an Impressive Social Media Platform

Tech entrepreneur Zach Marks adds more innovation and content to a safe space for kids

Read More Stories

More Canopy Growth Corporation (CGC) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CGC News